Publications
Clinical immunology (Orlando, Fla.)Apr 2023 |
251
109316
DOI:
10.1016/j.clim.2023.109316

Characterization of AR-CGD female patient with a novel homozygous deletion in CYBC1 gene presenting with unusual clinical phenotype

Chiriaco, Maria; De Matteis, Arianna; Cifaldi, Cristina; Di Matteo, Gigliola; Rivalta, Beatrice; Passarelli, Chiara; Perrone, Chiara; Novelli, Antonio; De Benedetti, Fabrizio; Insalaco, Antonella; Palma, Paolo; Finocchi, Andrea
Product Used
NGS
Abstract
Chronic granulomatous disease (CGD) is a human IEI caused by mutations in genes encoding the NADPH oxidase subunits, the enzyme responsible for the respiratory burst. CGD patients have severe life-threatening infections, hyperinflammation and immune dysregulation. Recently, an additional autosomal recessive AR-CGD (type 5) caused by mutations in CYBC1/EROS gene was identified. We report a AR-CGD5 patient with a novel loss of function (LOF) homozygous deletion c.8_7del in the CYBC1 gene including the initiation ATG codon that leads to failure of CYBC1/EROS protein expression and presenting with an unusual clinical manifestation of childhood-onset sarcoidosis-like disease requiring multiple immunosuppressive therapies. We described an abnormal gp91phox protein expression/function in the patient's neutrophils and monocytes (about 50%) and a severely compromised B cell subset (gp91phox 
Product Used
NGS

Related Publications